Search This Blog

Tuesday, August 13, 2019

Crinetics Pharmaceuticals EPS misses by $0.05

Crinetics Pharmaceuticals (NASDAQ:CRNX): Q2 GAAP EPS of -$0.51 misses by $0.05.
Cash, equivalents and investments of $145M.
Press Release
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)